| Breakdown | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 93.89B | 84.16B | 82.84B | 68.09B | 56.95B |
| Gross Profit | 26.50B | 20.77B | 15.68B | 13.52B | 9.88B |
| EBITDA | 33.86B | 30.23B | 25.53B | 22.09B | 17.89B |
| Net Income | 16.63B | 15.19B | 12.11B | 9.41B | 6.47B |
Balance Sheet | |||||
| Total Assets | 435.82B | 406.71B | 367.01B | 338.62B | 337.89B |
| Cash, Cash Equivalents and Short-Term Investments | 42.06B | 42.69B | 46.92B | 40.58B | 46.46B |
| Total Debt | 297.23B | 262.11B | 232.79B | 209.96B | 209.40B |
| Total Liabilities | 319.06B | 284.00B | 250.74B | 224.23B | 225.70B |
| Stockholders Equity | 116.66B | 111.71B | 105.51B | 103.84B | 101.78B |
Cash Flow | |||||
| Free Cash Flow | -31.84B | -33.50B | -18.01B | -13.44B | 862.00M |
| Operating Cash Flow | -21.66B | -28.45B | -9.81B | -2.92B | 6.66B |
| Investing Cash Flow | 3.42B | 5.36B | -1.29B | 5.81B | 7.78B |
| Financing Cash Flow | 20.81B | 19.57B | 17.79B | -6.58B | -15.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥128.57B | 20.19 | 15.81% | 2.93% | 53.39% | 67.02% | |
73 Outperform | ¥4.42T | 16.16 | 9.64% | 0.97% | -1.33% | 25.13% | |
70 Outperform | ¥217.13B | 7.44 | 16.39% | 2.38% | 11.56% | 14.99% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | ¥739.22B | 6.28 | 10.59% | 2.94% | 2.34% | -10.23% | |
62 Neutral | ¥72.04B | 3.41 | ― | 2.89% | 33.75% | -0.68% | |
56 Neutral | ¥914.31B | 5.42 | 7.40% | 3.68% | 24.40% | 11.46% |